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Abstract
1-phenyl 2-thiourea (PTU) is a tyrosinase inhibitor commonly used to block pigmentation and aid visualization of zebrafish
development. At the standard concentration of 0.003% (200 mM), PTU inhibits melanogenesis and reportedly has minimal
other effects on zebrafish embryogenesis. We found that 0.003% PTU altered retinoic acid and insulin-like growth factor
(IGF) regulation of neural crest and mesodermal components of craniofacial development. Reduction of retinoic acid
synthesis by the pan-aldehyde dehydrogenase inhibitor diethylbenzaldehyde, only when combined with 0.003% PTU,
resulted in extraocular muscle disorganization. PTU also decreased retinoic acid-induced teratogenic effects on pharyngeal
arch and jaw cartilage despite morphologically normal appearing PTU-treated controls. Furthermore, 0.003% PTU in
combination with inhibition of IGF signaling through either morpholino knockdown or pharmacologic inhibition of tyrosine
kinase receptor phosphorylation, disrupted jaw development and extraocular muscle organization. PTU in and of itself
inhibited neural crest development at higher concentrations (0.03%) and had the greatest inhibitory effect when added
prior to 22 hours post fertilization (hpf). Addition of 0.003% PTU between 4 and 20 hpf decreased thyroxine (T4) in thyroid
follicles in the nasopharynx of 96 hpf embryos. Treatment with exogenous triiodothyronine (T3) and T4 improved, but did
not completely rescue, PTU-induced neural crest defects. Thus, PTU should be used with caution when studying zebrafish
embryogenesis as it alters the threshold of different signaling pathways important during craniofacial development. The
effects of PTU on neural crest development are partially caused by thyroid hormone signaling.
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Introduction
Zebrafish (Danio rerio) are small fresh-water tropical fish that
have gained popularity as a vertebrate model for biological
research over the past 20 years [1]. Zebrafish are particularly
amenable for studying organismal development because of their
small size, extracorporeal development, and accessibility for
forward and reverse genetics. Unlike mammalian models, in vivo
imaging of live zebrafish embryos, combined with transgenic
approaches, can yield real-time viewing of development [2].
Through the use of real time experiments as well as standard
molecular techniques (ie. in situ hybridization and immunostaining)
employed at specific time points, zebrafish models have yielded
significant insights into embryogenesis, organogenesis, tissue
regeneration and pathogenesis.
For optimal analysis, zebrafish embryos should remain
transparent to achieve optical clarity during in vivo imaging and
easy detection of whole mount color reagents. Pigmentation begins
around 24 hours post fertilization (hpf; 5 prim stage) in the retinal
pigment epithelium and then extends throughout the skin by
48 hpf [3,4]. Most commonly, embryos are treated with the
tyrosinase inhibitor 1-phenyl 2-thiourea (PTU) to block endoge-
nous melanogenesis [3,5]. The tyrosinase enzyme is required to
form the two intermediates (L-dopa and dopaquinone) in the
conversion from tyrosine to melanin [6]. Addition of PTU prior to
24 hpf effectively but reversibly inhibits pigmentation until
approximately 120 hpf.
For the purpose of inhibiting pigmentation, PTU is typically
used at a concentration of 0.003% (200 mM) [7] which reportedly
has no effect on zebrafish embryonic heart rate [1], catecholamine
synthesis, or xanthophore and iridophore differentiation [8].
However, at this concentration, PTU added at the 28 somite-
stage has been demonstrated to cause mild teratogenesis (posterior
malformation and protruding lower snout), delayed hatching, and
mortality by 120 hpf [3] in approximately one-third of embryos.
In fact, Karlsson and colleagues found that PTU at a
concentration of 70 mM that is added to the media at the 28
somitic stage minimizes mortality and teratogenic effects, but still
maintains transparency. Furthermore, PTU at a concentration of
0.003% has been reported to inhibit thyroid function similar to
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goitrogens [5,9]. It is unknown whether the toxic effects of PTU
are through inhibition of thyroid hormone. Despite these findings,
the standard concentration of PTU cited in most protocols
remains 0.003% (200 mM).
To bypass the need for PTU, additional strategies such as the
use of zebrafish strains that have decreased levels or absence of
pigment have been employed. One example is the roy orbison (roy)
strain which is a naturally occurring mutant that has decreased
melanocytes and lacks autofluorescence due to absence of
iridophores [10]. By comparing phenotypes in a wildtype
background in the presence of 0.003% PTU to phenotypes in a
roy strain, we found that PTU interacts with the teratogen retinoic
acid as well as other signaling pathways such as insulin-like growth
factor (IGF) to influence craniofacial and extraocular muscle
development. Importantly, while 0.003% PTU treatment alone
(control treatment) resulted in embryos that lacked pigment but
were otherwise morphologically normal, a higher concentration of
PTU, or earlier treatment, inhibited cranial neural crest
development.
From these studies we conclude that the use of PTU in
combination with pharmacologic treatments or genetic manipu-
lations of zebrafish embryos, even at 0.003%, can mask or alter
phenotypes, and particularly those affecting neural crest and
craniofacial development.
Materials and Methods
Zebrafish care, mutants and transgenics
Zebrafish (Danio rerio) were raised in a laboratory breeding
colony on a 14 hour light/10 hour dark cycle. Embryos were
maintained at 28.5 degrees Celsius and staged as described [4]. Tg
(sox10::EGFP) strain was the generous gift of Thomas Schilling
[11,12]. The Tg (fli::EGFP) strain was obtained from ZIRC
(Eugene, OR). The Tg(a-actin::EGFP) strain was a generous gift of
Dr. Simon Hughes, [13]. These transgenic strains were crossed
into the roy background [10], which was the generous gift of
Rachel Wong, to decrease endogenous fluorescence. The
protocols have met guidelines established by the University of
Michigan Committee on the Use and Care of Animals.
Phenylthiourea treatment
1-phenyl 2-thiourea (PTU; Sigma, St. Louis, MO) was dissolved
in water to 0.3%, and diluted in embryo media to the indicated
concentrations (0.003% to 0.03%) at specific developmental time
points (6 to 22 hpf).
Morpholinos Oligonucleotide (MO) Injections
Antisense oligonucleotide morpholinos (MOs) were synthesized
by Gene Tools, LLC (Cowallis, OR) and reconstituted in de-
ionized water. MO sequences for igf1ra, igf1rb, and standard
control (globin) were previous published [14]. The concentration of
MO for each gene that yielded consistent and reproducible
phenotype was determined. MO sequences were lissamine-tagged
for fluorescent tracking. 1 nl of MO (0.1–0.25 mM) was injected
into the yolk of 1–2 cell stage embryos.
Embryos were analyzed with a Leica M205FA combi-scope
(Leica, Germany) using a Leica DFC290 (brightfield imaging) and
Hamamatsu ORCA-ER (fluorescent imaging) cameras (Hama-
matsu, Japan).
Pharmacological Treatment of Embryos
All-trans retinoic acid (Sigma), diethylbenzaldehyde (DEAB;
Sigma), picropodophyllin (PPP; Calbiochem, La Jolla, CA),
triiodothyronine (T3; Sigma), or thyroxine (T4; Sigma), were
dissolved in dimethylsulfoxide (DMSO) to 10006 of final
concentration. The pharmacologic agents were added to embryo
media to their final concentrations (retinoic acid 0.1 nM to 1 mM;
DEAB 10–20 mM; PPP 2–10 mM; T3 100 nM; T4 100 nM) at the
indicated time. 0.1% DMSO served as control. Exogenous
treatment was initiated at the developmental time as indicated.
At the cessation of treatment, the embryos were washed in embryo
media 3 times and then raised in fresh embryo media until the
designated time. Embryo media was changed every 24 hours with
fresh pharmacologic agent as indicated until the embryos were
harvested.
Wholemount Immunostaining for Thyroxine
Embryos were harvested at 96 hpf and fixed in 2% trichlor-
oacetic acid for 3 hours at room temperature. Embryos were then
washed in PBS/1% triton and blocked in 10% normal goat serum
in PBS/1% triton for 2 hours. Embryos were incubated with
rabbit anti-thyroxine (T4) polyclonal antibody (1:1000; MP
Biochemicals, Solon, OH) in 1% normal goat serum in PBS/1%
triton overnight at 4 degrees Celsius. Embryos were washed
multiple times with PBS/1% triton and then incubated overnight
at 4 degrees Celsius with goat anti-rabbit IgG conjugated with Cy3
(Abcam, Cambridge, MA) in 1% normal goat serum in PBS/1%
triton. Embryos were washed multiple times with PBS/1% triton
and then analyzed microscopically.
Results
PTU Modulates Retinoic Acid Regulation of Craniofacial
Development
Retinoic acid is well-recognized for its influence on craniofacial
development both as an essential morphogen as well as a teratogen
[15,16,17,18,19]. Using transgenic zebrafish strains that express
GFP in neural crest or differentiated muscle (Tg(sox10::EGFP) and
Tg(a-actin::EGFP), respectively) [20] we found that 0.003% PTU
modulated retinoic acid regulation of extraocular muscle devel-
opment and neural crest development. We were able to abrogate
the need for PTU by crossing the transgenic lines into a roy
background, thereby creating the roy Tg(sox10::EGFP) and roy
Tg(a-actin::EGFP) strains. In the absence of PTU by using the roy
Tg(a-actin::EGFP) strain, treatment with 10 mM DEAB at 24 hpf
inhibited pharyngeal arch formation but had minimal effect on
jaw and extraocular muscle development at 72 hpf (Figure 1A,B
compared to Figure 1I,J) [20]. In the presence of 0.003% PTU
which was added to the media at 12 hpf, treatment with 10 mM
DEAB at 24 hpf caused thickening and overlapping of extraocular
muscles as well as poor formation and occasional absence of the
oblique muscles (Figure 1C,D) Importantly addition of only
0.003% PTU at 12 or 22 hpf did not alter craniofacial
development (Figure 1K,L compared to Figure 1I,J; Figure S1D
compared to Figure S1C; Figure S2C,D compared to Figure 1I,J)
at 72 hpf. Addition of 0.003% PTU after 22 hpf did not alter the
DEAB-induced extraocular muscle phenotype (Figure S2A,B and
S2C,D, compared to Figure 1A,B). This DEAB-induced extrao-
cular muscle phenotype in the presence of PTU could not be fully
recapitulated in the roy background in the absence of PTU by
increasing the concentration of DEAB (15–20 mM; Figure S2E,F)
or initiating treatment with DEAB at 18 hpf (Figure S2G,H).
Higher concentrations of DEAB started at 24 hpf in combination
with PTU at 12 hpf resulted in death by 96 hpf.
We next tested whether the effect of exogenous retinoic acid on
craniofacial development was also modulated by PTU. In the roy
background, treatment with exogenous retinoic acid (100 nM)
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pharyngeal arch formation by 72 hpf (Figure S1A compared to
Figure S1C) and craniofacial muscle development (Figure 1E,F
compared to Figure 1I,J). Addition of 0.003% PTU to the media
at 12 hpf effectively decreased the teratogenic effects of exogenous
retinoic acid (100 nM) as pharyngeal arch formation was
incompletely inhibited (Figure S1B compared to Figure S1A). In
addition, primitive jaw muscles that were not connected in the
midline (Figure 1G,H) were observed in embryos treated with
retinoic acid in the presence of 0.003% PTU.
Since PTU altered the effects of both inhibition of synthesis and
treatment with retinoic acid on craniofacial development, we
assessed whether PTU modulated the sensitivities to retinoic acid
of the jaw and pharyngeal arches. We determined the effect of
PTU on the rescue of DEAB-induced defects by exogenous
retinoic acid. In the roy background, treatment with 0.1 nM
retinoic acid at 28 hpf did not rescue the effects 10 mM DEAB at
24 hpf on the pharyngeal arches or jaw (Figure 2A compared to
Figure 1A). Retinoic acid at 1 nM improved DEAB-induced
defects in pharyngeal arch and jaw formation (Figure 2C
compared to Figure 1A). Retinoic acid at 10 nM and 100 nM,
not only reversed the effects of 10 mM DEAB but also had
teratogenic effects on the jaw and pharyngeal arches (Figure 2E
and Figure 2G). The addition of 0.003% PTU at 12 hpf improved
pharyngeal arch formation in the presence of a combination of
exogenous retinoic acid (0.1 nM, 1 nM, 10 nM, 100 nM) and
10 mM DEAB (Figure 2B,D,F,H compared to Figure 1G and
Figure 2A,C,E,G). Furthermore, 0.003% PTU decreased the
teratogenic effect of exogenous retinoic acid on jaw development
(Figure 2H compared to Figure 2G). Thus, treatment with 0.003%
PTU at 12 hpf effectively lowered craniofacial sensitivity to
retinoic acid.
PTU Modulates IGF Regulation of Craniofacial
Development
Once we determined that PTU modulates retinoic acid
regulation of craniofacial and extraocular muscle development,
we also investigated whether other signaling pathways may be
affected by PTU. Insulin-like growth factor (IGF) is a ubiquitous
and evolutionarily conserved pathway that regulates cellular
proliferation, differentiation, migration, and survival [21]. IGF
predominantly signals through IGF1 receptor (IGF1R), which in
zebrafish has undergone gene duplication (igf1ra and igf1rb).
Previous studies have demonstrated that morpholino oligonucle-
otide knockdown of each receptor individually caused mild growth
and developmental delay by 24 hpf. Knockdown of both igf1ra and
igf1rb resulted in severe growth and developmental inhibition [14].
IGF1R signaling is also thought to participate in the
pathogenesis of thyroid eye disease, in which neural crest-derived
orbital fibroblasts undergo proliferation and transdifferentiation
[22]. Given our interest in craniofacial and periocular disorders
involving neural crest-derived tissues, we studied the effect of IGF
Figure 1. PTU modulates retinoic acid regulation of craniofacial muscles. 72 hpf Tg(a-actin::EGFP) embryos (ventral view) were treated with
10 mM DEAB (A–D) at 24 hpf, 100 nM retinoic acid (RA) (E–F) at 28 hpf, , or 0.1% dimethylsulfoxide (DMSO; I–L) in the roy background (in the absence
of PTU; A, B, E, F, I, J) or in the presence of 0.003% PTU which was added to the media at 12 hpf (C, D, G, H, K, L). 10 mM DEAB in the presence of PTU
caused thickening of the inferior rectus (C, D) and absence of the inferior oblique (IO) compared to treatment with DEAB in the roy background
(absence of PTU; A, B). In addition, only 1 pharyngeal arch (PA) was present in embryos treated with DEAB and PTU (C). Embryos treated with DEAB
alone had 2 pharyngeal arches (A) while the control embryos had 4 pharyngeal arches (I). Exogenous retinoic acid inhibited craniofacial muscle
development which was worse in the absence of PTU (G. H compared to E, F). AM, anterior mandibulae.
doi:10.1371/journal.pone.0022991.g001
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the roy background and in the absence of PTU, morpholino
knockdown of igf1ra (1 nl of 0.25 mM) or igf1rb (1 nl of 0.25 mM),
either alone or together caused minimal difference in craniofacial
structure (Figure 3A,E compared to Figure 3I) including cartilage
(Figure S3A,C,E compared to Figure S3G) and muscle formation
at 96 hpf (Figure 3B,F compared to Figure 3J). In the presence of
0.003% PTU added at 12 hpf, knockdown of igf1ra caused delay
(Figure 3C compared to Figure 3K) of normal neural crest-derived
jaw and pharyngeal arch development (Figure S3B compared to
Figure S3H) and jaw and extraocular muscle formation (Figure 3D
compared to Figure 3L), but the overall morphology was normal.
However, addition of 0.003% PTU at 12 hpf to morpholino
knockdown of igf1rb disrupted jaw formation (Figure S3D,
Figure 3G,H) and caused slightly thickened extraocular muscles
(Figure 3H), revealing subfunctionalization of igf1r paralogs.
Injection of a combination of both igf1ra (0.1 mM) and igf1rb
(0.1 mM) morpholinos in the presence of 0.003% PTU starting at
12 hpf resulted in severely malformed embryos that had gross
heart and yolk sac edema, maldeveloped jaw and pharyngeal
arches, and shortened body and tail at 96 hpf (Figure S3F, data
not shown). Using concentrations of igf1ra and igf1rb morpholino
that were used in the single knockdown experiments (0.25 mM
each) resulted in death by 30 hpf as previously described (data not
shown) [14].
In order to identify specific stages during which IGF signaling is
required for craniofacial development, we used picropodophyllin
(PPP), an inhibitor of IGF1R tyrosine kinase receptor phosphor-
ylation, which was added to the embryo media at different time-
points. Similar to the morpholino knockdown experiments, we
found that the PPP-induced phenotype was altered by the addition
of 0.003% PTU at 12 hpf. In the roy background and in the
absence of PTU, treatment with 10 mM PPP at different time
points (10–12 hpf, 20–24 hpf, or 24–96 hpf) did not disrupt
embryonic development (Figure 4A–C compared to Figure 4D,).
Higher concentrations of PPP (up to 100 mM) likewise did not
affect craniofacial development (data not shown). The only finding
in the absence of PTU was that PPP treatment from 10–12 hpf
caused decreased skin pigmentation (data not shown). In the
presence of 0.003% PTU added at 12 hpf, embryonic develop-
ment was sensitive to PPP at concentrations of 2–5 mM, and
higher concentrations resulted in death (data not shown). In the
presence of 0.003% PTU, treatment with 2 mM PPP from 10–
12 hpf did not alter craniofacial development (Figure 4E com-
pared to Figure 4J). However, treatment with 2 mM PPP from 16
to 24 hpf caused jaw and pharyngeal arch malformation with
thickening of extraocular muscles at 96 hpf (Figure 4F compared
to Figure 4J). A concentration of 5 mM PPP applied at either 10 to
12 hpf or 16 to 24 hpf caused death when added in combination
with 0.003% PTU. Treatment with 2 mM PPP from 24 to 30 hpf,
30 to 36 hpf, or 36 to 48 hpf caused minimal disruption of
craniofacial development (Figure 4G–I) in the presence of 0.003%
PTU. Treatment with 5 mM PPP from 24 to 30 hpf in the
presence of 0.003% PTU did not affect craniofacial development
(Figure 4G compared to Figure 4N). Treatment with 5 mM PPP
from 30 to 36 hpf in the presence of 0.003% PTU resulted in
maldeveloped jaws in which craniofacial cartilages failed to adhere
to each other (Figure 4L compared to Figure 4N); minor
manipulation of these embryos dislodged the jaw, and the
craniofacial musculature was disorganized and also poorly
connected. Treatment with 5 mM PPP from 36 to 48 hpf in the
presence of 0.003% PTU caused a malformed jaw that did not
protrude at 96 hpf (Figure 4M compared to Figure 4N). Taken
together, these results demonstrate that 0.003% PTU renders
Figure 2. PTU alters sensitivity of craniofacial tissues to
retinoic acid. 72 hpf Tg(a-actin::EGFP) embryos (ventral view) were
treated with 10 mM DEAB at 24 hpf and increasing concentrations of
retinoic acid (RA; 0.1 nM, 1 nM, 10 nM, 100 nM) at 28 hpf in the roy
background (in the absence of PTU; A, C, E, G) or presence of 0.003%
PTU added at 12 hpf (B, D, F, H). In the roy background and in the
absence of PTU, 1 nM retinoic acid improved the DEAB-induced effects
on pharyngeal arch formation (C), but at higher concentrations (10 nM
(E) and 100 nM (G)), retinoic acid suppressed pharyngeal arch
development. DEAB-induced extraocular muscle disorganization in
the presence of PTU (Figure 1A, B) was rescued by 0.1 nM retinoic
acid (B). The DEAB effects on pharyngeal arch development in the
presence of PTU was improved by 1 nM (D) and rescued by 10 nM
retinoic acid (F). Teratogenic effects of retinoic acid on jaw musculature
and pharyngeal arches were lessened in the presence of PTU (F, H
compared to E, G). IR, inferior rectus; IO, inferior oblique; AM, anterior
mandibulae.
doi:10.1371/journal.pone.0022991.g002
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inhibiting a redundant pathway.
Effects of PTU on craniofacial development are
dependent on concentration and developmental stage
PTU at a concentration of 0.003% was previously shown to
cause mild teratogenesis and delayed hatching [3], with a dose-
dependent response leading to severe malformations and death at
higher concentrations [9]. Given the interaction between PTU,
retinoic acid and IGF1R in the regulation of craniofacial
development, we decided to test whether PTU itself had toxic
effects on the neural crest in two well-established transgenic
strains, Tg(fli1::EGFP) or Tg(sox10::EGFP). We compared the toxic
effects of PTU (0.003% and 0.03%) on embryos treated at 6 or
22 hpf. Treatment with 0.003% PTU at 6 or 22 hpf caused
delayed hatching (data not shown) but overall did not affect
craniofacial development (Figure 5A–H) compared to 96 hpf
untreated Tg(fli1::EGFP) or Tg(sox10::EGFP) crossed into the roy
background (Figure 5Q–T). This included the formation of
hyaloid-retinal blood vessels (Figure 5B,F compared to
Figure 5R) in the eye, or neural crest-derived pharyngeal arches
(Figure 5C,G compared to Figure 5S) or jaw cartilages
(Figure 5D,H compared to Figure 5T). Embryos treated at
22 hpf with 0.003% PTU showed more pigment at 96 hpf
(Figure 5E) than those treated at 6 hpf (Figure 5A). Treatment
with a 10-fold increase in PTU (0.03%) at 6 hpf inhibited growth
and development (Figure 5I) and resulted in near-total suppression
of neural crest development (Figure 5I–L). In addition, the hyaloid
vessels developed but did not remodel to form the retinal-hyaloid
vasculature (Figure 5J). Treatment with 0.03% PTU at 22 hpf
resulted in malformed jaw (Figure 5M,P) and pharyngeal arches at
96 hpf (Figure 5O,P), but did not affect hyaloid-retinal vasculature
formation (Figure 5N). Thus, the toxic effects of PTU are
dependent on the concentration and developmental stage at
which it is added to the media.
Effects of PTU on craniofacial development are partially
mediated by disruption of thyroid signaling
Previous studies demonstrated that treatment with 0.003%
PTU starting at 6 hpf decreased thyroxine (T4) in thyroid follicles
of the nasopharynx of 5 days post fertilization (dpf) embryos [9].
The role of thyroid hormone on neural crest development is not
well defined, despite the expression of thyroid receptor (TR) aA
and aB early in the developing neural crest [23]. Prior to 60 hpf,
the yolk sac contains maternal stores of thyroid hormone and is
the predominant source [9,24]. The first evidence of thyroid
follicles and endogenous triiodothyronine (T3) and T4 production
occurs at about 60 hpf. Zebrafish is an established model for
studying the effects of environmental and medicinal goitrogens on
thyroid signaling and development of thyroxine-producing
Figure 3. PTU alters IGF regulation of craniofacial muscle development. 72 hpf Tg(a-actin::EGFP) embryos that were injected with
morpholinos against igf1ra (A–D), igf1rb (E–H), or control (globin; I–L) and were raised in control media (A, B, E, F, I, J) or with 0.003% PTU at 12 hpf (C,
D, G, H, K, L). Morpholino knockdown of igf1ra or igf1rb in the roy background (in the absence of PTU; A, B, E, F) did not disrupt craniofacial
development as compared to control (I, J). Morpholino knockdown of igf1ra in the presence of 0.003% PTU caused developmental delay only in the
presence of 0.003% PTU (C, D compared to K, L). Knockdown of igf1rb inhibited jaw formation and caused mild thickening of extraocular muscles in
the presence of 0.003% PTU (G, H), but not in control media (E, F). IR, inferior rectus; IO, inferior oblique; AM, anterior mandibulae.
doi:10.1371/journal.pone.0022991.g003
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when it is added prior to 22 hpf, we investigated whether these
toxic effects are mediated through inhibition of thyroid hormone
signaling.
We first used wholemount immunostaining to detect T4 in
thyroid follicles scattered in the nasopharynx in embryos raised in
control media (Figure 6A,B) and those treated with 0.003% PTU.
As previously demonstrated, early treatment (4 to 12 hpf) with
Figure 4. Craniofacial development is sensitive to IGF signaling and PTU during different time frames. 72 hpf Tg(a-actin::EGFP) embryos
were treated with the tyrosine kinase receptor inhibitor, picropodophyllin (PPP; 2–10 mM) at different times in the roy background (in the absence of
PTU; A–D) or in the presence of 0.003% PTU added at 12 hpf (E–K). Treatment with PPP between 10–12 hours had minimal effect on craniofacial
development (A, E) regardless of treatment with 0.003% PTU. In the roy background and in the absence of PTU, treatment with 10 mM PPP between
20 and 24 hpf (B), or 24 and 96 hpf (C) did not affect craniofacial development compared to 0.1% DMSO control (D). Treatment with 2 mM PPP
between 16 and 24 hpf in the presence of 0.003% PTU caused craniofacial maldevelopment and thickening of extraocular muscles (F) compared to
0.1% DMSO control (J). Treatment with 2 mMo r5mM PPP between 24 and 30 hpf caused mild delay of jaw development in the presence of PTU (G).
Treatment with 2 mM PPP between 30 and 36 (H) or 36 and 48 (I) hpf did not affect craniofacial development. Treatment with 5 mM PPP between 30
and 36 hpf in the presence of PTU caused poor adherence of the jaw (G) and dissolution of muscle structure after tissue manipulation (L) compared
to 0.1% DMSO control (N). Treatment with 5 mM PPP from 36 to 48 hpf caused abnormal jaw and pharyngeal arch formation in the presence of
0.003% PTU (M). Treatment with PPP in the absence of PTU did not affect craniofacial development (M–T). IR, inferior rectus; IO, inferior oblique; AM,
anterior mandibulae.
doi:10.1371/journal.pone.0022991.g004
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(Figure 6C–E). Treatment with 0.003% PTU between 16 and
24 hpf resulted in more conspicuous T4 staining in the follicles
(Figure 6F,G) until no effect was noted when PTU treatment
began at 24 hpf (Figure 6H). This suggests that the time frame of
PTU-inhibition of thyroid follicle development correlates with the
effects of PTU on retinoic acid or IGF signaling.
To further investigate whether inhibition of thyroid signaling
mediates the effect of PTU on neural crest development, we tested
whether PTU defects were rescued with exogenous T3 and T4.
Roy Tg(sox10::EGFP) embryos treated with exogenous 100 nM T3
and 100 nM T4 starting at 6 or 22 hpf showed mild downward
displacement of jaw cartilage, frontal bossing, and decreased
pigmentation (Figure 7A–D) at 96 hpf. Exogenous T3 and T4 in
combination with 0.003% PTU starting at 6 or 22 hpf until 96 hpf
resulted in mild displacement of jaw cartilage and frontal bossing
(Figure 7E–H compared to Figure 5A,D,E,H). T3 and T4
improved, but did not rescue neural crest-derived jaw develop-
ment in embryos treated with 0.03% PTU at 6 hpf (Figure 7I,J
compared to Figure 5I,L) or 22 hpf (Figure 7K,L compared to
Figure 5M,P). Addition of exogenous 100 nM T3 and 100 nM T4
only between 6 and 22 hpf did not affect craniofacial development
in the absence of PTU (Figure S4A,B) or in the presence of
0.003% PTU added at 6 hpf (Figure S4C,D). Furthermore,
exogenous T3 and T4 between 6 and 22 hpf did not improve
neural crest defects induced by treatment with 0.03% PTU from 6
Figure 5. PTU at high concentrations inhibits neural crest development. 96 hpf roy Tg(fli1::EGFP) and roy Tg(sox10::EGFP) embryos were
treated with 0.003% (A–H) or 0.03% (I–P) PTU at 6 hpf or 22 hpf. Treatment with 0.003% PTU at 6 (A–D) or 22 (E–H) hpf inhibited pigmentation (A, E)
but did not affect development of the retinal-hyaloid vasculature (B, F), pharyngeal arches (PA; C, G), and jaw cartilage (D, H) as compared to
untreated embryos (Q–T). At a concentration of 0.03%, PTU at 6 hpf inhibited neural crest development (I–L) including pharyngeal arch development
(K), jaw formation (L), and the remodeling of the hyaloid vessel into the hyaloids retinal plexus (J). Treatment with 0.03% PTU at 22 hpf caused
pharyngeal arch (O) and jaw malformation (M, P), but did not affect the hyaloid-retinal vasculature (N).
doi:10.1371/journal.pone.0022991.g005
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these results suggest that PTU effect on neural crest development
may be partly due to inhibition of thyroid hormone signaling.
We next determined whether exogenous T3 and T4 rescued
PTU-suppression of T4 in thyroid follicles in 96 hpf embryos. T4
staining was decreased in embryos treated with 0.003% or 0.03%
PTU at 6 hpf (Figure S5D,G) compared to untreated embryos
(Figure S5A). Treatment with 100 nM T3 and 100 nM T4
between 6 and 22 hpf did not effect T4 staining in 96 hpf embryos
that were raised in the absence (Figure S5B) or presence of PTU
(0.003% or 0.03%; Figure S5E,H). Treatment with T3 and T4 at
6 hpf did not rescue the effect of 0.003% PTU on T4 staining
(Figure S5F), but did mildly improve T4 staining in embryos
treated with 0.03% PTU (Figure S5I). Taken together these results
demonstrate that PTU disrupts thyroid hormone signaling and
endogenous production of thyroxine, and this pathway may be
involved in mediating the effects of PTU on neural crest
development.
Discussion
PTU has long been used to inhibit pigmentation in various
amphibian and fish models [3,5,6]. As a tyrosinase inhibitor, PTU
blocks the synthesis of melanin from tyrosine as well as the
intermediates required for catecholamine synthesis. In addition,
PTU has been shown to inhibit thyroid signaling and follicle
development, similar to other known goitrogens [9]. In the current
study we demonstrate that PTU has sub-threshold effects on
craniofacial development in addition to the notable decreased
pigmentation, particularly vis-a `-vis retinoic acid and IGF1R
signaling.
Retinoic acid gradients in the craniofacial region are critical for
ocular, jaw and pharyngeal arch development [15,16,17,20]. We
found that the addition of 0.003% PTU at 12 hpf, but not 22 hpf,
altered the effects of both retinoic acid deficiency and excess on
these structures, as well as on extraocular muscle development.
Extraocular muscle development is mediated by signaling and
genetic pathways that are distinct from those of branchiomeric
muscles (muscles of mastication) or somitic muscles [25], and are
generally poorly understood. Studies in zebrafish and chick have
shown that signals arising from the developing eye and the cranial
neural crest development are required for extraocular muscle
morphogenesis [26,27,28] and that the homeobox gene pitx2
appears to be central to these interactions [20]. Retinoic acid,
which is produced by the eye at the time of cranial neural crest
migration and just prior to extraocular muscle development, is a
known regulator of pitx2 in both mouse [29] and zebrafish [20].
Pitx2 is required for activating muscle-specific transcription factors
such as Myf5, Myog, Myod1, Smyd1, Msc and Csrp3 in the prechordal
mesoderm [30,31], and mice deficient for Pitx2 lack extraocular
muscles [32]. Morpholino knockdown of pitx2a in zebrafish, unlike
mice, did not disrupt extraocular muscle development [20]. This
species difference may be due multiple pitx2 isoforms and the
possibility that pitx3 may functionally substitute for pitx2a in the
zebrafish. However, the addition of 0.003% PTU caused
thickened and disorganized extraocular muscles in the pitx2
morpholino knockdown (unpublished data), which was similar to
the effect of PTU in the context of reduced retinoic acid signaling.
Thus, PTU effects on the periocular mesenchyme render
extraocular muscle development (and possibly other nearby
structures) more susceptible to retinoic acid deficiency.
In addition to its effects on extraocular muscles, we found that
PTU modulated neural crest development in conjunction with
disruption of IGF signaling. IGF is required for normal
embryogenesis [21], and disruptions in IGF signaling have been
associated with oncogenesis and disease [33,34,35]. In the orbit,
IGF1R activation has been implicated in stimulating the
pathologic behavior of neural crest-derived tissues in thyroid eye
disease [22]. Limited information is known about the environ-
mental and genetic factors that predispose people with autoim-
mune-related alterations in thyroid levels (i.e. Graves disease and
Hashimoto’s thyroiditis) to develop thyroid eye disease. In the
current studies, we found that PTU seemed to pattern the neural
crest to make it more dependent on IGF signaling. This could
Figure 6. 0.003% PTU Inhibits T4 in thyroid follicles. Whole-
mount immunostaining for T4 in 96 hpf embryos (ventral view) raised
in control media (A, B) or in media containing 0.003% PTU. PTU was
added at 4, 8, 12, 16, 20, or 24 hpf and carried through until the
embryos were harvested at 96 hpf. Untreated 96 hpf embryos showed
numerous thyroid follicles that contained T4 (A, B). Addition of 0.003%
PTU between 4 and 12 hpf suppressed T4 in follicles at 96 hpf (C, E).
Addition of 0.003% PTU between 16 and 20 hpf progressively increases
T4 staining and treatment at 24 hpf does not affect T4.
doi:10.1371/journal.pone.0022991.g006
PTU Alters Zebrafish Neural Crest Development
PLoS ONE | www.plosone.org 8 August 2011 | Volume 6 | Issue 8 | e22991suggest that sub-threshold alterations in neural crest patterning
due to genetic or environmental influences during early develop-
ment may lead to increased vulnerability of orbital tissues to
alterations in IGF signaling in the pathogenesis of thyroid eye
disease.
PTU has previously been shown to inhibit thyroid hormone
signaling in zebrafish [9]. Although endogenous thyroid hormone
synthesis does not occur until ,60 hpf in zebrafish embryos, the
yolk sac contains maternal stores of T3 and T4 [24,36,37]. The
thyroid receptors and deiodinase enzymes that regulate synthesis
and degradation of thyroid hormone are expressed well before the
appearance of thyroid follicles [23,37,38]. At a concentration of
0.003%, PTU added prior to 24 hpf decreased thyroxine in
thyroid follicles at 96 hpf. Thus, PTU at an early developmental
stage interferes with the development of endogenous thyroid
hormone production later in embryogenesis. Treatment with high
levels of exogenous T3 and T4 improved but did not rescue jaw
formation in embryos treated with high concentrations of PTU.
Thus, the effect of PTU on the neural crest is partly mediated by
thyroid hormone. The aryl hydrocarbon receptor (AHR) is
another pathway that may also mediate the toxic effects of PTU,
since activation of AHR is associated with craniofacial malforma-
tions that include disruption of jaw development [39,40,41,42,43].
Further studies are needed to determine additional targets of PTU
in neural crest and craniofacial development.
Alternate strategies for maintaining transparency of zebrafish
embryos that do not involve the use of PTU have included the use
of strains that have decreased pigmentation and auto-fluorescence.
In the current studies, we used the roy orbison strain which lacks
iridophores, but does have skin and eye pigmentation [10] and is
particularly useful when using transgenic strains that express
fluorescent proteins. On the other hand, the nacre strain lacks skin
melanin but contains iridophores [10]. The embryos are
transparent except for the retinal pigment epithelium and are
appropriate for non-fluorescent applications such as color reaction
wholemount in situ hybridization and immunostaining. The double
mutant combining the roy orbison and nacre mutations constitutes
the casper strain which lacks skin pigmentation and iridophores
[10]. The casper strain can be used for all of the above mentioned
applications. However, in our experience, the casper strain is less
robust and more difficult to breed and maintain. Unlike treatment
with PTU, all of the above mentioned strains maintain
pigmentation of the retinal pigment epithelium. The sandy mutant,
which carries a mutation in the tyrosinase gene [8], lacks both skin
and eye pigmentation, but has not been a commonly used strain. A
recent study used the sandy strain to demonstrate that PTU effect
on eye size and retinal development was independent of loss of
tyrosinase function (Li and Leung, personal communication),
suggesting that the sandy strain may be especially useful in studying
ocular development.
In the current studies, we demonstrate that the commonly used
tyrosinase inhibitor PTU latently altered early developmental
processes. These effects manifest when combined with pharmaco-
logic or genetic disruption of other (presumably redundant)
Figure 7. Thyroid hormone partially mediates PTU effect on neural crest. 96 hpf roy Tg(sox10::EGFP) embryos were treated with 100 nM T3/
100 nM T4 and 0.003% (E–H) or 0.03% (I–L) PTU at 6 hpf or 22 hpf. High concentrations of T3 and T4 in the absence of PTU caused thickening of jaw
cartilage and frontal bossing (A–D)) when added at 6 or 22 hpf. Treatment with 0.003% PTU lessened the effects of exogenous T3 and T4 (E–H
compared to I–L). 100 nM T3/100 nM T4 improved, but did not restore the neural crest defects induced by treatment with 0.03% PTU at 6 (I, J
compared to Figure 5I, L) or 22 hpf (K, L compared to Figure 5M, P). PA, pharyngeal arches.
doi:10.1371/journal.pone.0022991.g007
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causing craniofacial abnormalities. As a result, we caution the use
of PTU in the study of zebrafish development as it may give rise to
different phenotypes and mask the true role of the studied genes.
Supporting Information
Figure S1 PTU lessens teratogenic effect of retinoic acid
on neural crest. 72 hpf Tg(sox10::EGFP) embryos (ventral view)
were treated with 100 nM retinoic acid (RA; A,B) at 28 hpf or
0.1% dimethylsulfoxide (DMSO; I–L) in the roy background (in
the absence of PTU, A, C) or presence of 0.003% PTU (B, D)
which was added to the media at 12 hpf. Exogenous retinoic acid
inhibited neural crest-derived pharyngeal arch (PA) formation,
which was worse in the absence of PTU (B, D compared to A, C).
(TIF)
Figure S2 Effect of PTU is time sensitive. 72 hpf Tg(a-
actin::EGFP) embryos treated with PTU at 22 hpf and 10 mM
DEAB (A, B) at 24 hpf showed shortening of the jaw and only 2
pharyngeal arches, but minimal effect on extraocular muscle
development compared to 0.1% DMSO (C, D). In the roy
background and in the absence of PTU, treatment with 15 mM
DEAB at 24 hpf (E, F) or 10 mM DEAB at 18 hpf (G, H) also
disrupted jaw and pharyngeal arch formation, but did not cause
thickening or loss of extraocular muscles.
(TIF)
Figure S3 PTU alters IGF regulation of neural crest
development. 72 hpf Tg(sox10::EGFP) embryos (ventral view)
that were injected with morpholinos against igf1ra (A, B), igf1rb (C,
D), igf1ra/igf1rb (E, F) or with a control (globin; G, H) and were
raised in control media (roy background, A C, E, G) or media
supplemented with 0.003% PTU at 12 hpf (B, D, F, H).
Morpholino knockdown of igf1ra caused mild developmental delay
only in the presence of 0.003% PTU (B compared to A, G, H).
Knockdown of igf1rb or both igf1ra and igf1rb inhibited jaw and
pharyngeal arch (PA) formation in the presence of 0.003% PTU
(D, F), but not in control media (C, E).
(TIF)
Figure S4 T3 and T4 are required after 22 hpf for
rescue of PTU. 96 hpf roy Tg(a-actin::EGFP) were treated with
100 nM T3 and 100 nM T4 from 6 to 22 hpf in the absence (A, B)
or presence of 0.003% (C, D) or 0.03% (E, F) PTU from 6 to
96 hpf. Exposure to exogenous T3 and T4 only between 6 and
22 hpf in the absence of PTU (A, B) or in the presence of 0.003%
PTU (C, D) did not cause frontal bossing or displacement of jaw
cartilage as was seen with exposure to T3 and T4 from 6 to 96 hpf
(Figure 7A–D). Furthermore, exogenous T3 and T4 from 6 to
22 hpf did not rescue the craniofacial defects induced by 0.03%
PTU (E, F).
(TIF)
Figure S5 T3 and T4 partially restore T4 expression in
PTU-treated embryos. Wholemount immunostaining for T4
in 96 hpf embryos (ventral view) demonstrated that in the absence
of PTU exogenous treatment with 100 nM T3 and 100 nM T4
between 6 and 96 hpf mildly decreased T4 expression in thyroid
follicles (C) compared to embryos treated with T3 and T4 from 6
to 22 hpf (B) and untreated controls (A). Treatment with 0.003%
(D) and 0.03% PTU (G) progressively decreased T4 expression
compared to embryos raised in the absence of PTU (A).
Treatment with exogenous T3 and T4 from 6 to 22 hpf (E) or
from 6 to 96 hpf (F) did not improve the effect of 0.003% PTU on
T4 expression (D) while exogenous T3 and T4 from 6 to 96 hpf (I),
but not from 6 to 22 hpf (H) slightly improved T4 expression in
embryos treated with 0.03% PTU (G).
(TIF)
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